The study s primary end point was disease free survival, which was defined as the time from randomization to breast cancer recurrence, a second primary cancer excluding contralateral ductal carcinoma in situ, or death from any cause, whichever came first is doxycycline a strong antibiotic This is by no means a comprehensive post the meeting is enormous but I have also included several summary links below with additional information
The study s primary end point was disease free survival, which was defined as the time from randomization to breast cancer recurrence, a second primary cancer excluding contralateral ductal carcinoma in situ, or death from any cause, whichever came first is doxycycline a strong antibiotic This is by no means a comprehensive post the meeting is enormous but I have also included several summary links below with additional information